Editorial Advisory Board

Editor

Howard A. Burris III, M.D.
Chief Medical Officer & Director of Drug Development 
Sarah Cannon Research Institute
Nashville, Tennessee 

Associate Editors

Brain/CNS Tumors
Henry S. Friedman, M.D.
James B. Powell Jr. Professor of Neuro-Oncology
Professor of Pediatrics
Associate Professor of Surgery Medicine
Assistant Professor of Pathology
Deputy Director
Preston Robert Tisch Brain Tumor Center
Duke University
Durham, N.C.

Breast Cancer
William J. Gradishar, M.D.
Betsy Bramsen Professor of Breast Oncology
Director
Maggie Daley Center For Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital,
Chicago, Illinois

Hope S. Rugo, M.D.
Clinical Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California

Gastrointestinal Malignancies
Johanna C. Bendell, M.D.
Director, GI Oncology Research
Associate Director, Drug Development Unit
Sarah Cannon Research Institute
Nashville, Tennessee

Stuart M. Lichtman, M.D.
Professor of Medicine, Weill Cornell Medical College
Commack, New York
Attending Physician, Clinical Geriatrics Program, Memorial Sloan-Kettering Cancer Center
New York, New York

Malcolm J. Moore, M.D.
Professor of Medicine and Pharmacology
University of Toronto
Head, Division of Medical Oncology and Hematology, Princess Margaret Hospital/University Health Network and Mt. Sinai Hospital
Director, Drug Development Program, Chief of Medical Services, Princess Margaret Hospital
Toronto, Ontario

Genitourinary Malignancies
Judd W. Moul, M.D.
Professor and Chief, Division of Urologic Surgery
Director, Duke Prostate Center
Duke University
Durham, North Carolina

Walter M. Stadler, M.D.
Fred C. Buffett Professor of Medicine
Surgery Associate Dean for Clinical Research
Director, Genitourinary Program
University of Chicago Medical Center
Chicago, Illinois

With Daniel J. George, M.D.
Associate Professor of Medicine and Surgery
Divisions of Medical Oncology and Urology
Duke University
Durham, North Carolina

With Andrew J. Armstrong, M.D.
Assistant Professor of Medicine and Surgery
Divisions of Medical Oncology and Urology
Duke University
Durham, North Carolina

Gynecologic Malignancies
Maurie Markman, M.D.
Vice President for Medical Oncology Services
National Director of Medical Oncology
Cancer Treatment Centers of America
Eastern Regional Medical Center
Philadelphia, Pennsylvania

Head and Neck Cancer
Marshall R. Posner, M.D.
Director, Head and Neck Medical Oncology
Professor of Medicine
Professor of Gene and Cell Medicine
The Tisch Cancer Institute
Mount Sinai School of Medicine
New York, New York

Hematologic Malignancies: Leukemia, Myelodysplasia, and Transplantation
Steven E. Coutré, M.D.
Associate Professor of Hematology
Director, Hematology Clinic
Stanford University
Stanford, California

Hematologic Malignancies: Lymphoma and Plasma Cell Disorders
Kenneth C. Anderson, M.D.
Kraft Family Professor of Medicine
Harvard Medical School Chief
Division of Hematologic Neoplasia
Director, Jerome Lipper Multiple Myeloma
Center Dana-Farber Cancer Institute
Boston, Massachusetts

Lung Cancer
Roy S. Herbst, M.D., Ph.D.
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center
New Haven, Conn.

Vincent A. Miller, M.D.
Senior Vice President, Clinical Development
Foundation Medicine, Inc.
Cambridge, Massachusetts

Melanoma
Jeffrey A. Sosman, M.D.
Professor of Medicine
Vanderbilt-Ingram Cancer Center
Melanoma Program Co-leader
Signal Transduction and Cell Proliferation Program
Vanderbilt University, Section of Hematology/Oncology
Nashville, Tennessee

Pediatric Cancers
Gregory H. Reaman, M.D.
Professor of Pediatrics
The George Washington University
Washington, D.C.
Chairman
Children’s Oncology Group
Bethesda, Maryland

Sarcoma
George D. Demetri, M.D.
Director
Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Patient and Survivor Care
Charles L. Loprinzi, M.D.
Director, North Central Cancer Treatment Group (NCCTG) Cancer Control Program
Codirector, Prevention and Control Program for the Mayo Cancer Center
Professor of Oncology, Mayo Medical School
Rochester, Minnesota

Practice Trends
Lee S. Schwartzberg, M.D.
Medical Director
West Clinic President and Chief Medical Officer
Accelerated Community Oncology Research Network (ACORN)
Clinical Professor of Hematology, University of Tennessee Health Science Center
Memphis, Tennessee

Last updated November 18, 2011